Massar Omar

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Cross Sectional

Pulmonary Hypertension

Top Venues

European heart journal

Circulation. Heart failure

This page only lists publications with an associated author ORCID identifier.

Publications

Barry A Borlaug, Yogesh N V Reddy, Amanda Braun, Hidemi Sorimachi, Massar Omar, Dejana Popovic, Alessio Alogna, Michael D Jensen, Rickey E Carter
Cardiac and Metabolic Effects of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The CAMEO-DAPA Trial. Circulation (2023)
Jesper Jensen, Massar Omar, Caroline Kistorp, Christian Tuxen, Mikael Kjær Poulsen, Jens Faber, Lars Valeur Køber, Finn Gustafsson, Jacob Eifer Møller, Morten Schou
Effect of Empagliflozin on Multiple Biomarkers in Heart Failure: Insights From the Empire Heart Failure Trial. Circulation. Heart failure 15 (8) (2022)
Kazunori Omote, Hidemi Sorimachi, Masaru Obokata, Yogesh N V Reddy, Frederik Hendrik Verbrugge, Massar Omar, Hilary M DuBrock, Margaret M Redfield, Barry A Borlaug
Pulmonary vascular disease in pulmonary hypertension due to left heart disease: pathophysiologic implications. European heart journal 43 (36) (2022)
Hidemi Sorimachi, Frederik Hendrik Verbrugge, Kazunori Omote, Massar Omar, Masaru Obokata, Yogesh N V Reddy, Zi Ye, Hector I Michelena, Barry A Borlaug
Longitudinal Evolution of Cardiac Dysfunction in Heart Failure and Preserved Ejection Fraction With Normal Natriuretic Peptide Levels. Circulation 146 (6) (2022)